The stock of Opthea Limited ADR (OPT) has seen a -16.34% decrease in the past week, with a -33.46% drop in the past month, and a 31.52% flourish in the past quarter. The volatility ratio for the week is 7.99%, and the volatility levels for the past 30 days are at 6.03% for OPT. The simple moving average for the past 20 days is -21.06% for OPT’s stock, with a 4.33% simple moving average for the past 200 days.
Is It Worth Investing in Opthea Limited ADR (NASDAQ: OPT) Right Now?
Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OPT is 82.85M and currently, short sellers hold a 0.09% of that float. On November 15, 2024, OPT’s average trading volume was 25.72K shares.
OPT) stock’s latest price update
Opthea Limited ADR (NASDAQ: OPT)’s stock price has gone decline by -9.63 in comparison to its previous close of 3.74, however, the company has experienced a -16.34% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-10-10 that MELBOURNE, Australia, and Princeton, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be highlighted during the Innovate Retina Meeting on October 17, 2024, in Chicago, Illinois.
Analysts’ Opinion of OPT
Many brokerage firms have already submitted their reports for OPT stocks, with H.C. Wainwright repeating the rating for OPT by listing it as a “Buy.” The predicted price for OPT in the upcoming period, according to H.C. Wainwright is $14 based on the research report published on December 08, 2022 of the previous year 2022.
SVB Leerink, on the other hand, stated in their research note that they expect to see OPT reach a price target of $25. The rating they have provided for OPT stocks is “Outperform” according to the report published on April 26th, 2022.
Citigroup gave a rating of “Buy” to OPT, setting the target price at $48 in the report published on November 17th of the previous year.
OPT Trading at -18.79% from the 50-Day Moving Average
After a stumble in the market that brought OPT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.98% of loss for the given period.
Volatility was left at 6.03%, however, over the last 30 days, the volatility rate increased by 7.99%, as shares sank -32.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.42% upper at present.
During the last 5 trading sessions, OPT fell by -16.34%, which changed the moving average for the period of 200-days by +28.27% in comparison to the 20-day moving average, which settled at $4.28. In addition, Opthea Limited ADR saw 14.58% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OPT
Current profitability levels for the company are sitting at:
- -2369.38 for the present operating margin
- -0.66 for the gross margin
The net margin for Opthea Limited ADR stands at -1827.93. The total capital return value is set at -2.3. Equity return is now at value -3388.40, with -153.73 for asset returns.
Based on Opthea Limited ADR (OPT), the company’s capital structure generated 1.61 points at debt to capital in total, while cash flow to debt ratio is standing at -0.81. The debt to equity ratio resting at -2.65. The interest coverage ratio of the stock is -9.44.
Currently, EBITDA for the company is -200.02 million with net debt to EBITDA at -0.15. When we switch over and look at the enterprise to sales, we see a ratio of 4535.13. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.94.
Conclusion
To wrap up, the performance of Opthea Limited ADR (OPT) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
